MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by HIDAKA, H.
Right arrow Articles by TANAKA, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by HIDAKA, H.
Right arrow Articles by TANAKA, T.

Molecular Pharmacology, Vol 20, 571-578, Copyright © 1981 by the American Society for Pharmacology and Experimental Therapeutics

Activity-Structure Relationship of Calmodulin Antagonists

Naphthalenesulfonamide Derivatives

HIROYOSHI HIDAKA 1, MASAHISA ASANO 1, and TOSHIO TANAKA 1

1 Department of Pharmacology, Mie University School of Medicine, Edobashi, Tsu 514, Japan

The role of calmodulin in vascular response was investigated using two series of synthesized naphthalenesulfonamide derivatives. The actions of these compounds as calmodulin antagonists and vascular relaxants were shown to depend both on the chlorination of the naphthalene ring and on the length of the alkyl chain (C5-C10). A good correlation between potency in relaxation of these strips and affinity to calmodulin was obtained, thereby indicating that the mechanism of relaxation of these compounds is probably due to their effects on the Ca2+-calmodulin-dependent process. N-(6-Aminohexyl)-5-chloro-1-naphthalenesulfonamide (W-7) produced relaxation of contracted vascular strips with various contractile agonists, whereas this derivative contracted the strip in the absence of contractile agonists, suggesting that this contractile response produced by W-7 is masked in the presence of a contractile agonist. To clarify the mechanism of W-7-elicited contraction of vascular strips in the absence of contractile agonists, the effect of W-7 was examined on the spontaneous efflux of [3H]norepinephrine ([3H]NE) which had been preloaded to the strip; W-7 was compared with N-(6-aminohexyl)-1-naphthalenesulfonamide (W-5), a chlorine-deficient derivative of W-7 which has a lower affinity for calmodulin than does W-7. Both W-7- and W-5-induced contractions were associated with increases in the [3H]NE efflux and were inhibited by the addition of an alpha-adrenergic blocker, phentolamine. Other chlorine-deficient derivatives of W-7 which also had lower affinities for calmodulin increased the [3H]NE efflux with vascular strip contraction, suggesting no correlation between the potency in increasing the [3H]NE efflux and the affinity to calmodulin. Chlorine-deficient derivatives such as W-5 produced contraction in both the presence and absence of contractile agonists which were inhibited by phentolamine. Although W-7-induced relaxation of vascular strips was produced in the presence of Ca2+, the increase in [3H]NE efflux by W-7 and its derivatives was independent of Ca2+, suggesting that this increase in the [3H]NE efflux is not related to the Ca2+-calmodulin system. Thereby, W-7, a calmodulin antagonist, has at least two kinds of pharmacological actions: one is calmodulin-related relaxation and another is calmodulin-independent contraction. These chlorine-deficient derivatives seems to serve as so-called control agents of the calmodulin antagonist W-7, and these pairs of structually related naphthalenesulfonamides are useful tools with which to elucidate the function of calmodulin.

Note:
ACKNOWLEDGMENT We thank M. Ohara, Kyushu University, for critical reading of the manuscript.

Submitted on March 31, 1981
Accepted on June 11, 1981




This article has been cited by other articles:


Home page
Am. J. Physiol. Cell Physiol.Home page
K. Muller-Marschhausen, J. Waschke, and D. Drenckhahn
Physiological hydrostatic pressure protects endothelial monolayer integrity
Am J Physiol Cell Physiol, January 1, 2008; 294(1): C324 - C332.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Riondino, L. V. Lotti, L. Cutini, and F. M. Pulcinelli
Collagen-induced Platelet Shape Change Is Not Affected by Positive Feedback Pathway Inhibitors and cAMP-elevating Agents
J. Biol. Chem., February 25, 2005; 280(8): 6504 - 6510.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. E. Haskew-Layton, A. A. Mongin, and H. K. Kimelberg
Hydrogen Peroxide Potentiates Volume-sensitive Excitatory Amino Acid Release via a Mechanism Involving Ca2+/Calmodulin-dependent Protein Kinase II
J. Biol. Chem., February 4, 2005; 280(5): 3548 - 3554.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
T. Suzuki, H. Sakai, A. Ikari, and N. Takeguchi
Inhibition of Thromboxane A2-Induced Cl- Secretion by Antidiarrhea Drug Loperamide in Isolated Rat Colon
J. Pharmacol. Exp. Ther., October 1, 2000; 295(1): 233 - 238.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
C. Schöfl, T. Mader, C. Krämer, M. Waring, P. Krippeit-Drews, K. Prank, A. von zur Mühlen, G. Drews, and G. Brabant
Ca2+/Calmodulin Inhibition and Phospholipase C-Linked Ca2+ Signaling in Clonal {beta}-Cells
Endocrinology, December 1, 1999; 140(12): 5516 - 5523.
[Abstract] [Full Text]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1981 by the American Society for Pharmacology and Experimental Therapeutics